An official website of the United States government.

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Research Publications (Food Safety)

This page tracks research articles published in national and international peer-reviewed journals. Recent articles are available ahead of print and searchable by Journal, Article Title, and Category. Research publications are tracked across six categories: Bacterial Pathogens, Chemical Contaminants, Natural Toxins, Parasites, Produce Safety, and Viruses. Articles produced by USDA Grant Funding Agencies (requires login) and FDA Grant Funding Agencies (requires login) are also tracked in Scopus.

Displaying 501 - 525 of 704

  1. Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020

    • Emerging Infectious Diseases
    • A. K. Feehan et al.

      • COVID-19
  2. Using Virus Sequencing to Determine Source of SARS-CoV-2 Transmission for Healthcare Worker

    • Emerging Infectious Diseases
    • N. Safdar et al.

      • COVID-19
  3. SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease

    • Emerging Infectious Diseases
    • R. Perera et al.

      • COVID-19
  4. Small Particle Aerosol Exposure of African Green Monkeys to MERS-CoV as a Model for Highly Pathogenic Coronavirus Infection

    • Emerging Infectious Diseases
    • A. Totura et al.

      • COVID-19
  5. SARS-CoV-2 Natural Transmission from Human to Cat, Belgium, March 2020

    • Emerging Infectious Diseases
    • M. Garigliany et al.

      • COVID-19
  6. Potential Role of Social Distancing in Mitigating Spread of Coronavirus Disease, South Korea

    • Emerging Infectious Diseases
    • S. Park et al.

      • COVID-19
  7. Epidemiology of COVID-19 Outbreak on Cruise Ship Quarantined at Yokohama, Japan, February 2020

    • Emerging Infectious Diseases
      • COVID-19
  8. Asymptomatic Transmission of SARS-CoV-2 on Evacuation Flight

    • Emerging Infectious Diseases
    • S. Bae et al.

      • COVID-19
  9. Management of used personal protective equipment and wastes related to COVID-19 in South Korea

    • Waste Management & Research
    • With the rapid spread of coronavirus disease 2019 (COVID-19), the amount of used personal protective equipment (PPE) including face masks and protective clothes has significantly increased. This used PPE in a hospital can lead to the indirect infection by COVID-19. Accordingly, it has been recognized that the management of used PPE is very important to prevent the spread of COVID-19.

      • COVID-19
  10. The COVID-19 pandemic challenges the future

    • Waste Management & Research
      • COVID-19
  11. Keeping alive enterprises while embracing unprecedented COVID-19 restrictions

    • Therapeutic Advances in Infectious Disease
      • COVID-19
  12. Why such excess of mortality for COVID-19 in Spain?

    • Therapeutic Advances in Infectious Disease
      • COVID-19
  13. Preventing SARS-CoV-2 infection by blocking a tissue serine protease

    • Therapeutic Advances in Infectious Disease
    • Currently, there are no proven pharmacologic interventions to reduce the clinical impact and prevent complications of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, the cause of the ongoing Coronavirus Disease of 2019 (COVID-19) pandemic. Selecting specific pharmacological targets for the treatment of viral pathogens has traditionally relied in blockage of specific steps in their replicative lifecycle in human cells.

      • COVID-19
  14. Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: a narrative review

    • Therapeutic Advances in Infectious Disease
    • The predicament arising from the coronavirus disease 2019 (COVID-19) pandemic has become one of the most significant modern public health challenges. Despite uncertainties in the viral determinants and pathogenesis, it is crucial to accurately inspect all available evidence to construct accurate clinical guidelines for optimised patient care. This study aims to discuss the available evidence for the use of chloroquine (CQ) and hydroxychloroquine (HCQ) against COVID-19.

      • COVID-19
  15. Refugee camps and COVID-19: Can we prevent a humanitarian crisis?

    • Scandinavian Journal of Public Health
      • COVID-19
  16. Covid-19 and public health

    • Perspectives in Public Health
      • COVID-19
  17. COVID-19: the key to flattening the curve is health literacy

    • Perspectives in Public Health
      • COVID-19
  18. Sustaining and strengthening community resilience throughout the COVID-19 pandemic and beyond

    • Perspectives in Public Health
      • COVID-19
  19. Confronting the Upstream Causes of COVID-19 and Other Epidemics to Follow

    • International Journal of Health Services
    • The upstream causes of the COVID-19 pandemic have received little attention so far in public health and clinical medicine, as opposed to the downstream effects of mass morbidity and mortality. To resolve this pandemic and to prevent even more severe future pandemics, a focus on upstream causation is essential.

      • COVID-19
  20. We Must Take Advantage of This Pandemic to Make a Radical Social Change: The Coronavirus as a Global Health, Inequality, and Eco-Social Problem

    • International Journal of Health Services
    • COVID-19 not only constitutes a serious public health problem and a global major threat to the poorest and most vulnerable social groups and neighborhoods of the world, creating a potential pandemic of inequality, but also poses an enormous challenge from the perspective of public health, ethics, economy, environment, and politics.

      • COVID-19
  21. Comparison of COVID-19 Health Risks With Other Viral Occupational Hazards

    • International Journal of Health Services
    • The European Commission periodically classifies viruses on their occupational hazards to define the level of protection that workers are entitled to claim. Viruses belonging to Groups 3 and 4 can cause severe human disease and hazard to workers, as well as a spreading risk to the community. However, there is no effective prophylaxis or treatment available for Group 4 viruses.

      • COVID-19
  22. The Health of Indigenous Populations in South Asia: A Critical Review in a Critical Time

    • International Journal of Health Services
    • Despite South Asia’s promising social inclusion processes, staggering social and health inequalities leave indigenous populations largely excluded. Marginalization in the South Asian polity, unequal power relations, and poor policy responses deter Adivasi populations’ rights and opportunities for health gains and dignity. The ongoing COVID-19 pandemic is likely to result in a disproportionate share of infections and deaths among the Adivasis, given poor social conditions and exclusions.

      • COVID-19
  23. COVID-19 and the Mental Health of People From Refugee Backgrounds

    • International Journal of Health Services
    • Approximately 1 in 10 of the current 26 million people who are refugees reside in high-income countries. They have commonly experienced trauma related to violence, insecurity, persecution and shortage of food and medicine. Our research suggests that COVID-19 and its health and social sequalae may be triggering past traumatic reactions, exacerbating mental health problems and undermining functioning.

      • COVID-19
  24. The U.S. Health Care System on the Eve of the Covid-19 Epidemic: A Summary of Recent Evidence on Its Impaired Performance

    • International Journal of Health Services
    • Four decades of neoliberal health policies have left the United States with a health care system that prioritizes the profits of large corporate actors, denies needed care to tens of millions, is extraordinarily fragmented and inefficient, and was ill prepared to address the COVID-19 pandemic.

      • COVID-19
  25. COVID-19 and US Health Financing: Perils and Possibilities

    • International Journal of Health Services
    • While the COVID-19 pandemic presents every nation with challenges, the United States’ underfunded public health infrastructure, fragmented medical care system, and inadequate social protections impose particular impediments to mitigating and managing the outbreak. Years of inadequate funding of the nation’s federal, state, and local public health agencies, together with mismanagement by the Trump administration, hampered the early response to the epidemic.

      • COVID-19